Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.62 -0.03 (-4.88%)
As of: Oct 1, 2026 · 11:35 AM EDT

Biodexa Pharmaceuticals (BDRX) Non-Current Deferred Tax Liability (2014 - 2016)

Updated

Biodexa Pharmaceuticals (BDRX) reported Non-Current Deferred Tax Liability of $9.36 million for the quarter ended Jun 30, 2016.

Analysis

Biodexa Pharmaceuticals (BDRX) Non-Current Deferred Tax Liability (2014 - 2016) Analysis & Trends

As of Dec 31, 2015, Biodexa Pharmaceuticals posted Non-Current Deferred Tax Liability of $10.01 million.

  • By year, Non-Current Deferred Tax Liability came in at $583,393 in the year ended Dec 31, 2014.
  • The figure for the quarter ended Jun 30, 2016 ranks as the lowest quarterly Non-Current Deferred Tax Liability since the quarter ended Dec 31, 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Biodexa Pharmaceuticals 41.69 Mn 18.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 9.36 Mn
Dec 31, 2015 9.94 Mn
Dec 31, 2014 560,878.70
API Access

Biodexa Pharmaceuticals Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=BDRX&period=max&api_key=YOUR_API_KEY